Thromboangiitis obliterans: Difference between revisions
Line 23: | Line 23: | ||
==Management== | ==Management== | ||
*Abstinence from tobacco | |||
*Early symptoms w/o threatened tissue loss: outpatient vascular | |||
*Advanced disease: intra-arterial or intravenous PGE1, ASA, Heparin, arterial reconstruction, sympathectomy | |||
==Disposition== | ==Disposition== |
Revision as of 15:48, 6 February 2017
Background
- AKA Thromboangiitis Obliterates
Pathophysiology
- Idiopathic inflammatory occlusive disease of the hands and feet
- Exact pathogenesis unknown
Risk Factors
- Male, tobacco, Middle Eastern
- Virtually all patients are smokers
Clinical Features
Differential Diagnosis
Evaluation
- Clinical criteria for Dx (noninvasive testing not necessary)
- History of smoking
- Onset prior to <50 y/o
- Absence of atherosclerotic risk factors
- Upper limb involvement
- Infrapopliteal arterial occlusive lesions
Management
- Abstinence from tobacco
- Early symptoms w/o threatened tissue loss: outpatient vascular
- Advanced disease: intra-arterial or intravenous PGE1, ASA, Heparin, arterial reconstruction, sympathectomy